Homology Medicines' IPO

Homology Medicines raised a round of funding on March 28, 2018. Investors include Public.

Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into treatments for patients with rare diseases.…

Articles about Homology Medicines' IPO: